Microbot Medical’s Patent Wins Fail to Lift a Flat $0.95 Stock: Investor Concerns Rise
Microbot Medical’s recent patent wins fail to lift its flat‑priced $0.95 shares; investors see strategic inertia and a steep 29‑month decline, urging caution.
3 minutes to read